Evidence map›Paper›PMID 32518880›Full record

ArticleKidney international reports2020

Use of Bortezomib in the Treatment of C3 Glomerulonephritis Refractory to Eculizumab and Rituximab.

Jessica W Hui, Mindy Banks, Tibor Nadasdy, Brad H Rovin, Jordan K Abbott

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Jessica W HuiDepartment of Pediatrics, Immunodeficiency Diagnosis and Treatment Program, National Jewish Health, Denver, Colorado, USA.
Mindy BanksDepartment of Pediatrics, Nephrology Division, Rocky Mountain Hospital for Children, Denver, Colorado, USA.
Tibor NadasdyDepartment of Pathology, Ohio State University, Columbus, Ohio, USA.
Brad H RovinDepartment of Medicine, Nephrology Division, Ohio State University, Columbus, Ohio, USA.
Jordan K AbbottDepartment of Pediatrics, Immunodeficiency Diagnosis and Treatment Program, National Jewish Health, Denver, Colorado, USA.
The Ohio State University · USNational Jewish Health · USRocky Mountain Hospital for Children · USUniversity of Colorado Denver · US

Funding

Mechanisms of AIRE SAND-Domain Variants in AutoimmunityK08AI141734 · NIAID · UNIVERSITY OF COLORADO DENVER · PI ABBOTT, JORDAN · 2019 to 2023
$924k
NIAID NIH HHS K08 AI141734
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32518880
PMCPMC7270979
OpenAlexW3013515749

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.